Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
The research studies how maternal antibodies against influenza and tetanus affect the immune response of young horses (foals) when they are vaccinated against these diseases. It suggests that the timing of initial vaccinations should be delayed until the foal is at least six months old to account for the presence of these maternal antibodies.
Maternal Antibody Transfer and Its Implications
- The study observes that influenza and tetanus-specific antibodies of the IgG sub-isotypes are passed from the mother to foal through the consumption of colostrum, the first milk produced after birth. These antibodies can inhibit the foal’s own immune response to inactive influenza vaccines and tetanus toxin.
- High levels of specific sub-types of these antibodies were found in the foals after consuming colostrum, specifically foals from mares that received booster doses of multi-component vaccines in the last two months of their pregnancy.
- These antibodies declined exponentially over time but were still detectable when the foals reached 26 weeks (approximately six months) of age. This was true regardless of whether the foal was vaccinated before reaching this age.
- The study found that different types of these maternal antibodies declined at different rates.
The Impact of Maternal Antibodies on the Foal’s Response to Vaccination
- Yearlings (one-year-old horses) showed an increase in certain antibody levels after receiving two doses of a multi-component vaccine containing tetanus poison and inactivated influenza antigens. This did not include an increase in influenza IgA antibodies.
- However, yearlings did show a significant immune response to the tetanus vaccine in the form of increased tetanus IgGa, IgGb, and IgG(T) antibodies. A second dose boosted these levels even more, but did not result in an increase in tetanus IgA antibodies.
Recommendations from the Study
- The response of foals to vaccination followed a similar pattern to that observed in yearlings, but the antibody levels were generally lower.
- Interestingly, three-month-old foals showed no increase in certain antibodies in response to the first two vaccine doses and usually required one to three additional booster doses to achieve similar levels to yearlings after two doses.
- Considering the influence of maternal antibodies on the foal’s immune response, the study suggests deferring the primary Immunisation of foals born to vaccinated mares until they are at least six months old.
Concluding, the study provides critical insights into the interaction between maternal antibodies and the immune response of foals to vaccination. The suggested delay in initial immunization could be influential for veterinary practitioners in maximizing the effectiveness of the foal’s immune response to influenza and tetanus vaccinations.
Cite This Article
Publication
Researcher Affiliations
- Department of Medicine and Epidemiology (VM:VME), School of Veterinary Medicine, University of California, Davis 95616, USA.
MeSH Terms
- Adjuvants, Immunologic / administration & dosage
- Animals
- Animals, Newborn / immunology
- Animals, Suckling / immunology
- Antibodies, Bacterial / blood
- Antibodies, Viral / blood
- Colostrum / immunology
- Female
- Horse Diseases / immunology
- Horse Diseases / microbiology
- Horse Diseases / virology
- Horses
- Immunity, Maternally-Acquired
- Immunoglobulin G / analysis
- Immunoglobulin G / blood
- Influenza Vaccines / administration & dosage
- Influenza Vaccines / immunology
- Orthomyxoviridae Infections / immunology
- Orthomyxoviridae Infections / veterinary
- Pregnancy
- Tetanus / immunology
- Tetanus / veterinary
- Tetanus Toxoid / administration & dosage
- Tetanus Toxoid / immunology
- Time Factors
- Vaccination / methods
- Vaccination / veterinary
- Vaccines, Inactivated / administration & dosage
- Vaccines, Inactivated / immunology
Citations
This article has been cited 13 times.- Gomez DE, Wong D, MacNicol J, Dembek K. The fecal bacterial microbiota of healthy and sick newborn foals.. J Vet Intern Med 2023 Jan;37(1):315-322.
- Anna M, Łukasz M, Adam O, Chełmońska-Soyta A. Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life.. Sci Rep 2022 Sep 22;12(1):15795.
- Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.. Vaccines (Basel) 2022 Mar 4;10(3).
- Migdał A, Migdał Ł, Oczkowicz M, Okólski A, Chełmońska-Soyta A. Influence of Age and Immunostimulation on the Level of Toll-Like Receptor Gene (TLR3, 4, and 7) Expression in Foals.. Animals (Basel) 2020 Oct 26;10(11).
- Jürgenschellert L, Krücken J, Austin CJ, Lightbody KL, Bousquet E, von Samson-Himmelstjerna G. Investigations on the occurrence of tapeworm infections in German horse populations with comparison of different antibody detection methods based on saliva and serum samples.. Parasit Vectors 2020 Sep 10;13(1):462.
- Tallmadge RL, Miller SC, Parry SA, Felippe MJB. Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.. PLoS One 2017;12(5):e0177831.
- Hedegaard CJ, Heegaard PM. Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems.. Vet Immunol Immunopathol 2016 Jun;174:50-63.
- Beeler JA, Eichelberger MC. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.. Microb Pathog 2013 Feb;55:9-15.
- Gildea S, Arkins S, Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.. Influenza Other Respir Viruses 2010 Nov;4(6):363-72.
- Ryan C, Giguère S. Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses.. Clin Vaccine Immunol 2010 Dec;17(12):1896-902.
- Schwint ON, Ueti MW, Palmer GH, Kappmeyer LS, Hines MT, Cordes RT, Knowles DP, Scoles GA. Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential.. Antimicrob Agents Chemother 2009 Oct;53(10):4327-32.
- Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.. Equine Vet J 2009 Jan;41(1):87-92.
- Chen J, Zhang F, Fang F, Chang H, Chen Z. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.. BMC Infect Dis 2007 Oct 16;7:118.